Millennium Management’s Verona Pharma VRNA Stock Holding History

Millennium Management’s Portfolio VRNA Stock Details VRNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-9,700	Closed	-$1.04M	–	6507
2025 Q3	$1.04M	Sell	9,700 -4,300	-31%	-$449K	﹤0.01%	4606
2025 Q2	$1.32M	Buy	+14,000	New	+$1.04M	﹤0.01%	4210
2025 Q1	–	Sell	-20,000	Closed	-$929K	–	6444
2024 Q4	$929K	Buy	+20,000	New	+$751K	﹤0.01%	4262

Other funds holding VRNA

DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return

Millennium Management's VRNA Position: Q4 2025 in Review

Millennium Management sold out of Verona Pharma (VRNA) in Q4 2025, closing a stake of 1,796,738 shares — an estimated $192M sold.

Millennium Management first reported a position in VRNA in Q3 2020 and held it in 17 quarters. The position peaked at $192M in Q3 2025. 1 fund tracked by Wall St. Rank holds VRNA as of Q4 2025.

Millennium Management reported no remaining Verona Pharma position as of Q4 2025 after selling out during the quarter.
Millennium Management sold 1,796,738 Verona Pharma shares in Q4 2025, an estimated $192M.
Millennium Management first reported a position in Verona Pharma in Q3 2020 and held it in 17 quarters.
Millennium Management's Verona Pharma position peaked at $192M in Q3 2025.
1 fund tracked by Wall St. Rank held Verona Pharma as of Q4 2025.

Based on Millennium Management's 13F filing for Q4 2025, filed 17 Feb 2026.